Details for 2015733597

Up to date per 01.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON 2-((4S)-6-(4-CHLOROPHENYL)-1-METHYL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-YL)ACETAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015733597

EP Publication Number

3157928

E-Number

1096150

Language

PCT Number

US15036347

Publication Date

26.04.2017 A

13.02.2019 B1

Registration Date

13.02.2019

AT Publication Date

15.02.2019

Application Date

18.06.2015

Registration Number

Priorities

20.06.2014

201462014782 P

IPC

C07D 491/048 20060101AFI20180725BHEP

Maximum Duration of Protection

18.06.2035

Owner

Constellation Pharmaceuticals, Inc.215 First Street, Suite 200 Cambridge, MA 02142US

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

HALL, Michael L.155 Rosemont Street Albany, NY 12206US

Information about Fees